We describe the clinical and biochemical characteristics in three patients from two different families diagnosed with Congenital Disorder of Glycosylation type IIe owing to a defect in Conserved Oligomeric Golgi complex (COG)7; one of the eight subunits of the COG. The siblings and an unrelated single child of consanguineous parents presented with growth retardation, progressive, severe microcephaly, hypotonia, adducted thumbs, feeding problems by gastrointestinal pseudo-obstruction, failure to thrive, cardiac anomalies, wrinkled skin and episodes of extreme hyperthermia. A combined disorder in the biosynthesis of N-and O-linked glycosylation with hyposialylation was detected. Western blot analysis showed a severe reduction in the COG5 and 7 subunits of the COG. A homozygous, intronic splice site mutation (c.169 þ 4A4C) of the COG7 gene was identified in all patients. The phenotype is similar to that previously described in two patients of North African ethnicity with the same mutation, except for the lack of skeletal anomalies and only a mild liver involvement in our patients. We suggest performing protein glycosylation studies and Western blot for the different COG subunits in patients with progressive microcephaly, growth retardation, hypotonia, adducted thumbs and cardiac defects, especially in association with skin anomalies or episodes of hyperthermia. The presence of the characteristic phenotype might warrant direct DNA analysis.
Introduction
Congenital Disorders of Glycosylation (CDG) are a group of inherited, multisystem disorders caused by different defects in the biosynthesis of glycoconjugates. The first patients were described by Jaeken et al. 1 Since then numerous different defects have been reported. The first defect in one of the subunits of the Conserved Oligomeric Golgi (COG) complex was identified in 2004. 2 This multi protein complex consists of eight subunits, which are required for the proper structure and function of the Golgi system. 3, 4 The function of the COG system includes the preservation of the integrity of the Golgi, protein transport within the Golgi and between the endoplasmic reticulum (ER) and Golgi and the docking of glycosylation enzymes. 5 Defects in the COG complex result in multiple deficiencies in protein glycosylation. 5, 6 The different subunits form stable subcomplexes (COG2 together with 3 and 4 forms lobe A and COG5 together with 6 and 7 forms lobe B), where COG1 plays a role in the mediation of the Golgi complex association and COG8 helps the two subcomplexes to assemble into the complete COG complex. 6 The COG7 subunit was shown to be clinically deficient in two sibling suffering from a generalized protein glycosylation disorder presenting as a congenital multisystem disease. 2, 7 They showed a phenotype of dysmorphic facial features, microcephaly, adducted thumbs, skeletal anomalies, wrinkled skin, VSD, failure to thrive and a severe liver disease. Both siblings died at the age of a few weeks. Biochemical investigations showed increased lysosomal enzyme activities in plasma and a type 2 plasma transferrin isoelectric focusing (TIEF) pattern. O-glycosylation studies by isoelectric focusing of plasma apolipoproteinC-III (ApoC-III) showed increased hyposialylated isoforms. 7 The patients were found to have a homozygous point mutation IVS 1 þ 4A4C in a splice site of the COG7 gene. 2 Here, we report on three new patients with a COG defect and a similar phenotype.
Patients and methods

Patients
Patient 1 was born at term as the second female child of healthy, consanguineous parents (first cousins) of Maroccan origin. The pregnancy was complicated with oligohydramnion and placenta insufficiency. At birth weight was 2645 g (15th centile), length 44 cm (o3rd centile), and head circumference 31.5 cm (o3rd centile). Dysmorphic features were noted including upslanting and short palpebral fissures, a narrow and flat forehead with hypertrichosis, a flat malar region, a wide, and short nose, a smooth philtrum, a small mouth, retrognathia, thick gums, low-set, posterior-rotated ears and a short neck with wrinkled skin (Figure 1 ). Intermittent strabismus convergens was noted. She had adducted thumbs, overlapping, long fingers, a simian crease, contractures of the PIP and DIP joints with ulnar deviation of the hands. The extension movements in the hips and the knees and the flexion/extension of the elbows were slightly limited. She had a decreased muscle mass and muscle tone with decreased deep tendon reflexes. The newborn needed further hospitalization owing to recurrent episodes of hypoglycemia, pulmonary hypertension and muscle hypotonia. She received tube feeding for gastrointestinal pseudoobstruction. Periods of extreme hyperthermia (4411C) of unknown origin were observed. Repeated cranial ultrasound examination showed brain atrophy with cerebellar atrophy, corpus callosum hypoplasia, wide cerebral ventricles and mega-cisterna magna. Brain MRI did not show evidence for abnormal gyration. Ultrasound examination of muscles showed lower echodensity comparable with the picture seen in myopathy. The skeletal survey, liver ultrasound and ophthalmologic examination were normal. The echocardiogram detected a perimembranous VSD with ASD II and tricuspidal insufficiency. BERA evaluation confirmed a sensori-neural hearing loss. On EEG, there were paroxysmal changes with multi-focal sharp waves and generalized frontal activity (Table 1) . Serology for perinatal infections was negative. By further screening, laboratory investigations neither signs of kidney or liver dysfunction nor endocrine or metabolic anomalies were found. During the course of the disease, the ASAT and ALAT levels became gradually elevated up to 890 U/l without signs of cholestasis or icterus. The serum amino acids, acyl-carnitines profile, very long chain fatty acids, 7-dehydrocholesterol and urine organic acids were also normal, except for an elevated serum alanine level (820 mmol/l, C: o450 mmol/l). TIEF was abnormal showing a type 2 pattern. Blood creatine kinase (CK) levels varied between 144 and 760 U/l and up to 4035 U/l in fever episodes. Histologic evaluation of the muscle biopsy showed no specific anomalies. ATP production from pyruvate oxidation was decreased, but the activity of the respiratory chain complexes I, II, IV and of the pyruvate dehydrogenase complex was normal. Prometaphase karyotype analysis, Multiplex Ligation-dependent Probe Amplification for subtelomeric microdeletions, mutation analysis of the LCAM1 locus and FISH analysis for Prader Willi syndrome were normal.
The child had a severe growth delay and failure to thrive (weight: 4060 g (oP3 ¼ 7000 g), length: 53 cm (oP3 ¼ 64,5 cm) and head circumference: 34 cm (oP3 ¼ 42,5 cm)), when she died at the age of 9 months.
Patient 2 was born at term as the third, male child of the same parents. At birth weight was 2890 g (25th centile), length 42 cm (o3rd centile) and head circumference 33.5 cm (10th centile). A narrow and flat forehead with a low frontal hairline, short palpebral fissures, hypertelorism, a flat malar region, a wide, and short nose, a small mouth, retrognathia, low-set ears and a short neck with wrinkled skin (Figure 1 ) were noted. He had adducted thumbs, a simian crease, overlapping fingers with contractures of the PIP joints and ulnar deviation of the hands. He had a decreased muscle mass and muscle tonus with decreased deep tendon reflexes. The newborn needed further hospitalization secondary to severe pulmonary hypertension and urosepsis owing to obstructive uropathy. Blood CK levels (normal valueo200 U/l) varied between 180 and 360 U/l and up to 4000 U/l in fever episodes. He received tube feeding for gastrointestinal pseudoobstruction. He also had a severe multisystem disorder, comparable with that of his older sister, including microcephaly, dysmorphic features, hypotonia with peripheral joint contractures. Brain ultrasound and MRI showed brain atrophy with cerebellar atrophy and corpus callosum hypoplasia. Kidney ultrasound showed hydronephrosis on the left. Ophthalmologic examination was normal. Echocardiography detected a peri-membranous VSD with ASD II (Table 1) .
Laboratory investigations showed no signs of liver dysfunction or endocrine anomalies. The serum amino acids, acyl-carnitine profile, very long chain fatty acids, 7-dehydrocholesterol and urine organic acids were also normal. Blood CK activity was repeatedly elevated. The activities of several lysosomal enzymes (fucosidase, hexosaminidase and a-mannosidase) were mildly elevated in plasma. TIEF showed a type 2 pattern. The patient died at the age of 7 months.
Patient 3 was born at term as the second female child of healthy, consanguineous parents (first cousins) of Maroccan origin. At birth weight was 2300 g (o3rd centile), length 41 cm (o3rd centile) and head circumference 31.9 cm (o3rd centile). Dysmorphic features were noted, including upslanting and short palpebral fissures, a narrow and flat forehead, a flat malar region, a wide, and short nose, a smooth phyltrum, a small mouth, retrognathia, thick gums, low-set, posteriorly-rotated ears and a short neck with wrinkled skin ( Mutation in the COG7 gene with a consistent phenotype E Morava et al thumbs and overlapping, long toes and fingers. Axial tone was increased with tendency to opisthotonus. Brain MRI showed corpus callosum hypoplasia, wide cerebral ventricles and cortical-subcortical atrophy. The skeletal survey, liver ultrasound and ophthalmologic examination were normal. The echocardiogram was normal. On EEG, there were paroxysmal changes with multi-focal sharp spikes. At the age of 3 weeks, she was admitted with extreme temperature elevation up to 411C without proven infection. These episodes were repeated over the first year. Serology for perinatal infections was negative. By further screening laboratory investigations neither signs of kidney or liver dysfunction, nor endocrine or metabolic anomalies were found. During the course of the disease, the ASAT and ALAT levels became gradually elevated to 200 -350 U/l with increase of liver size to 3 cm under the costal margin. The serum amino acids, acyl-carnitine profile, very long chain fatty acids, 7-dehydrocholesterol were normal and urine organic acids showed increased ethylmalonic aciduria (four times elevated compared with controls). TIEF was not performed. Blood CK levels were always elevated and increased during temperature elevations, once up to 45.900 U/l. Histologic evaluation of the muscle biopsy showed no specific anomalies. Respiratory chain complexes I, II, IV and of the pyruvate dehydrogenase complex were normal. Prometaphase karyotype analysis, Multiplex Ligationdependent Probe Amplification for subtelomeric microdeletions were normal.
The child continued to have a failure to thrive, no developmental progress and episodes of extreme hyperthermia up to 421C associated with increased of ASAT, ALAT, LDH and CK. She died at the age of 8 months.
TIEF and ApoC-III
Transferrin is an N-glycosylated protein. Multiple isoforms occur in plasma with the tetrasialo-isoform being the most abundant. TIEF is used as a screening method for the detection of N-glycosylation defects. ApoC-III is an Oglycosylated plasma protein with equal amounts of disialoand monosialo-isoforms in addition to a very small amount of asialo-ApoC-III. ApoC-III isofocusing is used as a screening method for the detection of mucin-type core 1 O-glycan biosynthesis defects. The methods were carried out as described previously. Western blot analysis of the COG subunits Control and patient's fibroblasts were rinsed twice with icecold PBS and lysed on ice in cell lysis buffer (Tris-buffered saline supplemented with 1% Triton X-100 (Sigma, Bornem, Belgium) with protease inhibitor (Roche, Vilvoorde, Belgium) for 30 min. Insoluble material was removed by centrifugation at 13 000 g for 15 min at 41C. Proteins were quantified using the BCA kit (Pierce, Polylab, Merksem, Belgium). Equal quantities of protein were mixed with reducing 4 Â sample loading buffer (Invitrogen, Merelbeke, Belgium) containing 3% mercapto-ethanol (Sigma), incubated at 901C for 5 min and separated on 4 -12% precast gels (Invitrogen). Proteins were transferred on nitrocellulose membranes (Amersham, Diegem, Belgium) and nonspecific binding sites were blocked by incubation in TBS containing 0.1% (v/v) Tween-20 (Sigma) and 5%(w/v) nonfat dried milk. Further processing of the Western blot was performed by application of the appropriate primary and horseradish peroxidase-conjugated secondary antibodies in the same blocking buffer. The blots were developed using chemiluminiscence (Renaissance, Perkin Elmer, Zaventem, Belgium) and the signals of the different subunits were quantified using Image J software (http://rsb.info.nih.gov/ij/).
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Molecular genetic/sequence analysis
Mutation analysis on the index patients 1 and 3 was performed on cDNA for the genes COG2, COG3, COG4, COG5, COG6, COG7 and on genomic DNA for COG1 and COG8. Total RNA was isolated from patient's fibroblasts and a normal control using the RNeasy Kit (QIAGEN, Venlo, The Netherlands). The cDNA was then prepared with oligo-dT priming (Amersham) and Superscript III RNase (Invitrogen). Primers were designed to amplify the entire cDNA, for example, COG7 primers forward (CCGGAGCCAACTCTTAAGTTC) and reverse (GAAGA GATTCGGCAGCAAGT). Other primer sequences are available on request. A 0.4 ml cDNA sample was used in a total volume of 50 ml with DNA polymerase mix and buffer 1 of the expand long template PCR system (Roche). Amplification conditions were 2 min at 951C, 10 cycles of 10 s at 951C, 30 s at 651C (À11C each cycle) and 2 min at 681C followed by 25 cycles of 10 s at 951C, 30 s at 551C and 2 min at 681C.
Sequence analysis of the cDNA was performed in seven parts with overlapping ends using Big Dye Terminator v3.1 cycle sequencing kit on ABI 3100 Avant (Applied Biosystems, Nieuwerkerk a/d Ijsel, The Netherlands).
To confirm the presence of the COG7 mutation, exon 1 and the first part of intron 1 of the genomic DNA were amplified using the following primers: CCGGAGC CAACTCTTAAGTTC (F) and AGGGTATTTGCTGTCCATGC (R). Amplification conditions were 5 min at 951C, 20 cycles of 30 s at 951C, 30 s at 651C (À0,51C per cycle) and 30 s at 721C followed by 20 cycles of 30 s at 951C, 30 s at 551C and Mutation in the COG7 gene with a consistent phenotype E Morava et al 30 s at 721C. These conditions were also used for amplification of the exons and flanking intronic regions of COG1 and COG8. The DNA was isolated from fibroblasts of patients 1 and 3, and from leucocytes for patient 2.
Haplotype analysis Polymorphic markers (D16S412, D16S403, D16S417, D16S481), spanning a region of 800 kb around COG7, were used to elucidate the haplotype of the family members and a member of the first described family with a COG7 defect. 2 The PCR product (0.1 ml) was mixed with 0.1 ml Gene Scan 500 ROX size standard (Applied Biosystem) and 10 ml Hi-Di formamide (Applied Biosystems) and was put for 3 min on 951C. Analysis was performed with Gene Scan 3.7 (Applied Biosystems).
Results
Transferrin isoelectric focusing
Plasma samples from the patients (Patients 1 and 2, respectively) showed repeatedly an abnormal transferrin isofocusing pattern with a decrease of the tetrasialotransferrin isoforms (23 and 30%, controls: 52 -70%), but increase of hypoglycosylated transferrin isoforms ( Figure 3 ) in both siblings; asialo: 12 and 3%, controls: o3%; monosialo: 12 and 8%, controls o4%; disialo: both 17%, controls: o3 -11%, trisialo: 24 and 26%, controls: 4 -17%).
A protein polymorfism as the cause of an abnormal transferrin isofocusing profile was excluded by sialidase digestion. The presence of sialidase in the blood samples of both patients (either due to certain infections or improper blood sampling/handling) was excluded by enzyme activity measurement in serum, which showed no activity. The patients were classified as having an unidentified CDG type II, suggesting that the defect is situated in the processing of N-glycans localized in the Golgi. No analysis was performed in Patient 3.
ApoC-III isoelectric focusing
Plasma samples from the two patients analysed showed repeatedly an abnormal ApoC-III isofocusing profile (Figure 2 ). Patients 1 and 2, respectively, had the characteristic pattern of increased amounts of ApoC-III 0 (17 and 12%, controls: 0 -8%), normal amounts of ApoC-III 1 (57 and 66%, controls: 34 -58%) and decreased amounts of ApoC-III 2 (26 and 22%, controls: 40 -62%). The ApoC-III isoform distribution was comparable with one of the patients described with a CDG-IIe defect (COG7 in Figure 2 . 2,7,10 )
Western blot analysis of the COG subunits Compared with controls a significant decrease in the steady state levels of the lobe B subunits was found in Patients 1 and 2. Semiquantitative analysis of the reduced subunits showed 94% decrease for COG5, 73% decrease for COG6, 95% decrease for COG7 and 71% decrease for COG8 (Figure 3b ). These results are in accordance with results from previous experiments in COG7-deficient mammalian cells. Mutation in the COG7 gene with a consistent phenotype E Morava et al and activates at least two different cryptic splice sites, leading to the different transcripts. The same mutation was found in patient 2 (sibling of patient 1), and in Patient 3. The parents and a healthy sibling of patients 1 and 2 were heterozygous for the c.169 þ 4 A4C mutation. Mutation analysis of the other subunits of the COG complex in patients 1 and 3, did not detect any other pathogenic mutations.
Genetic analysis
Haplotyping with four polymorphic markers in the neighbourhood of COG7 showed that all three affected children were homozygous for the same haplotype of 680 kb around the COG7 gene (polymorphic markers D16S481 and D16S417). The previously described COG7 patient 5 (Table 1 ) from the study of Wu et al 2 had the same mutation and the same haplotype as the present patients. This patient is homozygous for the same haplotype of 800 kb with patients 1 and 2 around the COG7 gene (all four polymorphic markers).
Discussion
Patients with a serum transferrin IEF type 2 pattern, can be divided in subgroups, namely with normal and abnormal ApoC-III IEF profiles. 10 In our initial patients, a type 2 transferrin pattern was found together with an abnormal ApoC-III 0 profile. All COG-deficient patients, so far, show the same combination of IEF profiles. The finding of the characteristic biochemical 'pattern' by the initial metabolic screening could be very important in the diagnostics of patients with a suspected defect of the COG complex. Here, we report on three additional patients with a defect in the COG7 subunit of the COG complex. Intriguingly, the patients carry the same homozygous mutation c.169 þ 4 A4C as those described previously. 2 The c.169 þ 4 A4C point mutation impairs splicing at the canonical site and allows the use of a cryptic, conserved alternative splicing site near the first exon/intron boundary. One might consider the possibility of a mutation hot spot as the underlying aetiology for the common mutation. No known trinucleotide or tetranucleotide motifs are positioned at the mutation site, which have been proven to increase the frequency of this particular mutation. 12 Furthermore, according to our extended family history, the members of the three families carrying the COG7 mutations are not related. Interestingly, all families relocated from Africa; the patients described by Wu et al originated from Tunisia, whereas our patients are of Moroccan ancestry. The mutation presents within the same haplotype in all the three, so far described families, confirmed by haplotype analysis with markers spanning 680 kb around the COG7 gene. The common ethnic and genetic ancestry of large subgroups of Tunisian and Moroccan population could give an explanation for the overlapping haplotypes and the patients may share the same ancestral mutation. 13 This specific mutation could be a common North African mutation, however, this needs further investigations. The phenotypic features of the two patients are progressive microcephaly, characteristic facial features, intrauterine growth retardation, feeding difficulties owing to intestinal pseudoobstruction with failure to thrive, pronounced congenital hypotonia with adducted thumbs, cardiac anomalies, wrinkled skin and episodes of severe hyperthermia. The combination of profound microcephaly, adducted thumbs, heart defects and idiopathic hyperthermia is rather unique, and seldom reported in children. Neonatal hypotonia, distal finger contractures/ adducted thumbs and severe microcephaly have been described in patients with the adducted thumb syndrome (MIM 201550), which appears to be genetically heterogeneous. Our patients have many overlapping features with this syndrome, including the neonatal hypotonia, finger anomalies, microcephaly, ear anomalies, telecanthus, flat forehead, seizures and early death. Most patients however have no cardiac defects, but craniosynostosis or congenital brain malformations with contractures of the large joints, which were not present in the two siblings. 14, 15 A similar clinical phenotype is observed in children with a 1p36.3 chromosomal microdeletion, including hypotonia, neonatal short stature, growth delay, microcephaly, adducted thumbs, ear abnormalities, short palpebral fissures and microcephaly. 16 High-resolution chromosome analysis and MLPA studies for possible subterminal microdeletions, however, were normal in our patients.
Comparing the clinical features of the siblings with those previously described with a COG deficiency, we have found some overlapping features with children carrying mutations in the COG1 gene, including the multisystem involvement, hypotonia, growth delay, short stature, microcephaly, dysmorphic features and the hepatic involvement 8 (Table 1) . A somewhat similar clinical spectrum of symptoms has been observed in a patient with COG8 deficiency, including hypotonia, growth and developmental delay, short stature, strabismus and ataxia, comparable with the phenotype, observed in children with mitochondrial disorders (Table 1) . 17, 18 However, the children described with COG1 and with COG8 deficiency had a significantly milder clinical presentation. The proband with COG1 mutation had associated ventricular hypertrophy/ cardiac dysfunction and a rhizomelic short stature as well not present in our patients.
Regarding the patients described with the same COG7 mutation, we confirmed a consistent phenotype. The most pronounced difference compared with our patients was the presence of skeletal anomalies in the previously reported patients and a less pronounced liver involvement in our patients. Our patients on the other hand, had episodes of hypoglycemia, and severe recurrent episodes with hyperthermia. We propose that the few differences observed are comparable with the intra-familial variability seen in various metabolic disorders.
Our third patient was diagnosed without any previous metabolic screening, simply based on the characteristic clinical presentation especially the episodes of extreme hyperthermia. The presence of the suggestive phenotype therefore might warrant direct DNA analysis and could be sufficient to diagnose this new genetic syndrome.
